# Primary High-Grade Diffuse Large B-Cell Lymphoma of the Cecum: A Report of a Rare Case

**Authors:** Azhar K Adhad, Zuhair D Hammood, Omar Sultan, Waleed N Hosi, Sarhang S Abdalla, Harun A Ahmed, Berun Abdalla

PMC · DOI: 10.7759/cureus.99277 · Cureus · 2025-12-15

## TL;DR

A rare case of high-grade cecal lymphoma in a young man is reported, emphasizing the importance of considering lymphoma in cecal masses with nonspecific symptoms.

## Contribution

This paper presents a rare clinical case of primary cecal DLBCL in a young adult, highlighting diagnostic challenges and successful treatment.

## Key findings

- Primary high-grade DLBCL of the cecum was confirmed via histopathology and immunohistochemistry in a 22-year-old male.
- The patient's symptoms and imaging findings led to successful treatment after an inconclusive colonoscopy.
- A multidisciplinary approach is crucial for diagnosing and managing rare cecal lymphomas.

## Abstract

Primary diffuse large B-cell lymphoma (DLBCL) of the colon is rare and most commonly involves the cecum due to its rich lymphoid tissue. Diagnosis is often delayed because symptoms are nonspecific and endoscopic biopsies may be inconclusive. We report a case of high-grade cecal DLBCL in a 22-year-old male patient who presented with right-sided abdominal pain, weight loss, intermittent fever, and night sweats over three months. Examination revealed a palpable right iliac fossa mass, and imaging demonstrated a large cecal lesion with regional lymphadenopathy; however, colonoscopic biopsies were nondiagnostic. The patient underwent right hemicolectomy, and histopathology with immunohistochemistry confirmed high-grade DLBCL (CD20+, CD10+, BCL6+, Ki-67 ≈ 80%). Postoperatively, he developed a wound infection that was managed conservatively before initiating chemotherapy. This case illustrates that, despite its rarity and diagnostic challenges, cecal DLBCL can be successfully treated through a multidisciplinary approach. Clinicians should consider lymphoma in the differential diagnosis of cecal masses in young adults, particularly when B symptoms are present or biopsy results are inconclusive.

## Linked entities

- **Proteins:** MS4A1 (membrane spanning 4-domains A1), MME (membrane metalloendopeptidase), BCL6 (BCL6 transcription repressor), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** diffuse large B-cell lymphoma (MONDO:0018905), DLBCL (MONDO:0018905)

## Full-text entities

- **Genes:** MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}
- **Diseases:** lymphoma (MESH:D008223), DLBCL (MESH:D016403), cecal lesion (MESH:D002429), lymphadenopathy (MESH:D008206), fever (MESH:D005334), abdominal pain (MESH:D015746), weight loss (MESH:D015431), wound infection (MESH:D014946)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12802376/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12802376/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12802376/full.md

---
Source: https://tomesphere.com/paper/PMC12802376